tiprankstipranks
pc:paqth

PAQ Therapeutics

100 Summit Drive Burlington, MA 01803, US
https://www.paqtx.com/
PAQ Therapeutics is a biotechnology company focused on developing innovative KRAS degraders aimed at treating lethal cancers that currently lack effective treatment options. The company is advancing its lead candidate, PT0253, a potent and selective KRAS G12D degrader, through clinical trials to address critical unmet medical needs in oncology.

Leadership & Board

Current Number of Employees12
Current LinkedIn Followers1,497

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$116M
Total Amount Raised$116M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$77M
Latest Funding Amount$77M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

PAQ Therapeutics had 12 employees as of May 18, 2026. The number of employees increased by 1 (9.09%) week-over-week.
12Latest Employee Count
1(9.09%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

PAQ Therapeutics had 1,497 followers as of May 18, 2026. The number of followers increased by 3 (0.20%) week-over-week.
1,497Latest Followers Count
3(0.20%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 22, 2026
Series B
$77.00M
May 07, 2025
Series B
$39.00M

Investors

Related News and Analysis